ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Mitochondrial DNA Breaks and Copy Number and the Risk of Lung Cancer in the Shanghai Women's Health Study.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundLung cancer remains the leading cause of cancer mortality worldwide, and approximately one quarter of cases occur among individuals who never smoke. Mitochondria are highly susceptible to oxidative damage from environmental stressors, which can alter mitochondrial DNA (mtDNA) copy number (mtDNAcn) and induce mtDNA fragmentation. Although prior studies of mtDNAcn and lung cancer have yielded inconsistent results, the role of mtDNA fragmentation has not been examined.
methodsWe conducted a nested case-control study within the prospective Shanghai Women's Health Study, including 789 incident lung cancer cases among never-smoking women and 789 individually matched controls. Prediagnostic whole-blood samples were analyzed for mtDNA fraction with breaks (mtDNAfb) and mtDNAcn using high-throughput quantitative PCR assays. Conditional logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for lung cancer risk associated with mtDNAfb and mtDNAcn, adjusting for age, body mass index, and plate. We further assessed an interaction between mtDNAfb and mtDNAcn.
resultsHigher mtDNAfb was inversely associated with lung cancer risk, with 34% lower odds among participants with high mtDNAfb compared with those with low mtDNAfb (OR = 0.66; 95% CI, 0.51-0.85). Notably, a significant interaction was observed between mtDNAfb and mtDNAcn (P interaction = 8.3 × 10-6), with a stronger inverse association between mtDNAfb and lung cancer among women with low mtDNAcn.
conclusionsLower mtDNA fragmentation is associated with increased lung cancer risk among never-smoking women, particularly among those with low mtDNAcn. IMPACT: mtDNA fragmentation may represent a novel biomarker of impaired mitochondrial response to oxidative stress relevant to lung carcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.